Indian Pharmaceutical Companies and Accessibility of Drugs under TRIPS
Before the creation of the World Trade Organization (WTO) as the new permanent international trade organization, individual countries had the freedom to have their own patent laws. India was one of the countries which introduced a new patent law: the British Patents and Designs Act, 1911 was replaced by the Patents Act, 1970. The most striking feature of the new law was that it abolished product patents in drugs (and food). India had a long tradition of drug manufacturing. But the full potential could not be realized because of the constraints imposed by the Patents Act of 1911. The multinational corporations (MNCs) holding the drug patents used the then existing patent law to prevent the Indian generic companies from producing the new drugs.
KeywordsWorld Trade Organization Indian Company Compulsory Licence Bulk Drug Product Patent
Unable to display preview. Download preview PDF.